Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | LAP3 | P28838 | 3/20 | 0.51 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3783630 | 1.00 | MME (0.55) | MMEALDH1A1MAPTMEN1LMNA | |
| SCHEMBL31234069 | 1.00 | MME (0.55) | MMEALDH1A1MAPTMEN1LMNA | |
| SCHEMBL30494936 | 1.00 | MME (0.55) | MMEALDH1A1MAPTMEN1LMNA | |
| SCHEMBL30494645 | 1.00 | MME (0.55) | MMEALDH1A1MAPTMEN1LMNA | |
| SCHEMBL29349637 | 0.97 | MME (0.53) | MMEALDH1A1MAPTMEN1LMNA | |
| SCHEMBL29796739 | 0.97 | MME (0.53) | MMEALDH1A1MAPTMEN1LMNA | |
| SCHEMBL29630515 | 0.94 | MME (0.50) | MMEALDH1A1MAPTMEN1LMNA | |
| SCHEMBL30814482 | 0.94 | MME (0.50) | MMEALDH1A1MAPTMEN1LMNA | |
| SCHEMBL31514355 | 0.94 | MME (0.50) | MMEALDH1A1MAPTMEN1LMNA | |
| SCHEMBL29592701 | 0.94 | MME (0.50) | MMEALDH1A1MAPTMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4605407-A2 | METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS | Endevica Bio, Inc. (US) | 2025-08-27 | — | — | EP | claimed |
| US-12050228-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2024-07-30 | — | — | US | claimed |
| US-20240165006-A1 | DERMATOLOGICAL COMPOSTIONS AND USE THEREOF | BONE SCI. BIO LTD. (IL) | 2024-05-23 | — | — | US | claimed |
| WO-2024086381-A2 | METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS | ENDEVICA BIO, INC. (US) | 2024-04-25 | — | — | WO | claimed |
| EP-4313105-A1 | DERMATOLOGICAL COMPOSITIONS AND USE THEREOF | Bone Sci. Bio Ltd. (IL) | 2024-02-07 | — | — | EP | claimed |
| CN-117083075-A | Dermatological composition and use thereof | 邦赛生物有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-116199765-A | Method for synthesizing thymus by using modified dipeptide | 江苏诺泰澳赛诺生物制药股份有限公司 | 2023-06-02 | — | — | CN | claimed |
| US-20230130132-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING AMPHIPHILIC PEPTIDES AND METHODS OF USE THEREOF | BONE SCI. BIO LTD. (IL) | 2023-04-27 | — | — | US | claimed |
| EP-4125993-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING AMPHIPHILIC PEPTIDES AND METHODS OF USE THEREOF | Bone Sci. Bio Ltd. (IL) | 2023-02-08 | — | — | EP | claimed |
| WO-2022201146-A1 | DERMATOLOGICAL COMPOSITIONS AND USE THEREOF | BONE SCI. BIO LTD. (IL) | 2022-09-29 | — | — | WO | claimed |
| CN-115028682-A | Salt-increasing peptide from dry-cured ham and preparation method thereof | 合肥工业大学 | 2022-09-09 | — | — | CN | claimed |
| CN-113880936-B | Solid-phase synthesis method of abamectin | 浙江湃肽生物有限公司南京分公司 | 2022-03-29 | — | — | CN | claimed |
| CN-114032271-A | Oyster polypeptide and polypeptide powder with uric acid reducing effect as well as preparation method and application of oyster polypeptide and polypeptide powder | 浙江工业大学 | 2022-02-11 | — | — | CN | claimed |
| US-20210088539-A1 | AUTOMATED SAMPLE QUALITY ASSESSMENT | METABOLON, INC. | 2021-03-25 | — | — | US | claimed |
| US-10890592-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2021-01-12 | — | — | US | claimed |
| CN-110568196-B | Metabolic marker related to low-grade glioma in urine and application thereof | 中国医学科学院基础医学研究所 | 2020-09-18 | — | — | CN | claimed |
| CN-110568196-A | Metabolic marker related to low-grade glioma in urine and application thereof | 中国医学科学院基础医学研究所 | 2019-12-13 | — | — | CN | claimed |
| EP-0512435-B1 | Method of crystallizing aspartame | AJINOMOTO KK (JP) | 1997-01-22 | — | — | EP | claimed |
| US-5298648-A | Method of crystallizing aspartame | AJINOMOTO CO., INC. (JP) | 1994-03-29 | — | — | US | claimed |
| JP-3127737-A | — | — | None | — | — | JP | disclosed |
| JP-62151156-A | — | — | None | — | — | JP | disclosed |
| WO-2026107097-A1 | SELF-IMMOLATIVE LINKERS AND CONJUGATES THEREOF | ENLAZA THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| US-20260098072-A1 | METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS | ENDEVICA BIO INC (US) | 2026-04-09 | — | — | US | disclosed |
| EP-4707387-A2 | ATTENUATED DENGUE VIRUSES | Codagenix Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20260055137-A1 | NOVEL ISOLATED PEPTIDES, PROTEIN HYDROLYSATE COMPRISING THE SAID ISOLATED PEPTIDES AND USE THEREOF | BETAGRO PUBLIC COMPANY LIMITED (TH) | 2026-02-26 | — | — | US | disclosed |
| US-20260022384-A1 | ASPARAGINE SYNTHETASE INHIBITORS AND USES THEREOF | OSPEDALE SAN RAFFAELE S.R.L. (IT) | 2026-01-22 | — | — | US | disclosed |
| US-12497604-B2 | RNase-PON1 fusion polypeptides and related compositions and methods | THERIPION, INC. (US) | 2025-12-16 | — | — | US | disclosed |
| US-12428446-B2 | Peptide compound or pharmaceutically acceptable salt thereof | EYEBIO KOREA (KR) | 2025-09-30 | — | — | US | disclosed |
| EP-4605407-A2 | METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS | Endevica Bio, Inc. (US) | 2025-08-27 | — | — | EP | disclosed |
| CN-120230820-A | Method and kit for detecting colony number of bifidobacterium BL-99 inactivated bacteria before inactivation | 内蒙古伊利实业集团股份有限公司 | 2025-07-01 | — | — | CN | disclosed |
| CN-120230822-A | Method and kit for detecting colony number of bifidobacteria YLGB-1496 before inactivation of inactivated thallus | 内蒙古伊利实业集团股份有限公司 | 2025-07-01 | — | — | CN | disclosed |
| CN-115028682-B | Salty peptide derived from dry-cured ham and preparation method thereof | 合肥工业大学 | 2025-06-06 | — | — | CN | disclosed |
| US-20250154484-A1 | RNASE-PON1 FUSION POLYPEPTIDES AND RELATED COMPOSITIONS AND METHODS | THERIPION, INC. (US) | 2025-05-15 | — | — | US | disclosed |
| US-20250145977-A1 | METHODS FOR TREATING RHEUMATOID ARTHRITIS USING CTLA4-PON1 FUSION PROTEINS | THERIPION, INC. (US) | 2025-05-08 | — | — | US | disclosed |
| CN-119889726-A | Semen quality prediction method and system based on random forest | 深圳市疾病预防控制中心(深圳市卫生监督局、深圳市卫生检验中心、深圳市预防医学研究所) | 2025-04-25 | — | — | CN | disclosed |
| WO-2025044828-A9 | USE AND COMPOSITION OF POSTBIOTIC OF LACTOBACILLUS PARACASEI ET-22 | 内蒙古伊利实业集团股份有限公司 | 2025-04-03 | — | — | WO | disclosed |
| US-12259397-B2 | Biomarkers related to organ function | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2025-03-25 | — | — | US | disclosed |
| US-12258596-B2 | Polynucleotides encoding paraoxonase fusion polypeptides | THERIPION, INC. (US) | 2025-03-25 | — | — | US | disclosed |
| WO-2025044828-A1 | USE AND COMPOSITION OF POSTBIOTIC OF LACTOBACILLUS PARACASEI ET-22 | 内蒙古伊利实业集团股份有限公司 | 2025-03-06 | — | — | WO | disclosed |
| US-20250076302-A1 | DETECTING THE PRESENCE OF URINARY STONE DISEASE USING A PLURALITY OF URINARY METABOLITES | THE CLEVELAND CLINIC FOUNDATION | 2025-03-06 | — | — | US | disclosed |
| CN-119529799-A | Composite oil displacement agent for improving oil recovery efficiency and preparation method and application thereof | 中国石油天然气集团有限公司 | 2025-02-28 | — | — | CN | disclosed |
| US-20250059525-A1 | POLYNUCLEOTIDES ENCODING PARAOXONASE FUSION POLYPEPTIDES | THERIPION, INC. (US) | 2025-02-20 | — | — | US | disclosed |
| CN-119462875-A | Cold tolerance related protein OsCIP1 in booting stage of rice, coding gene and application | 中国农业大学 | 2025-02-18 | — | — | CN | disclosed |
| CN-119432795-A | Deoxyribotransferase mutant and preparation method, application and use method thereof | 苏州创美生物技术有限公司 | 2025-02-14 | — | — | CN | disclosed |
| EP-4483959-A2 | NOVEL PEPTIDE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | EYEBIO KOREA (KR) | 2025-01-01 | — | — | EP | disclosed |
| US-12178869-B2 | Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer | CODAGENIX INC. (US) | 2024-12-31 | — | — | US | disclosed |
| US-12180521-B2 | Paraoxonase fusion polypeptides and related compositions and methods | THERIPION, INC. (US) | 2024-12-31 | — | — | US | disclosed |
| US-12168049-B2 | Attenuated flaviviruses | CODAGENIX INC. (US) | 2024-12-17 | — | — | US | disclosed |
| EP-3974441-B1 | PEPTIDE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | EYEBIO KOREA (KR) | 2024-12-04 | — | — | EP | disclosed |
| US-12142472-B2 | Electrophoretic mass spectrometry probes and systems and uses thereof | PURDUE RESEARCH FOUNDATION (US) | 2024-11-12 | — | — | US | disclosed |
| CN-118895211-A | Deep sea bacillus atrophaeus NB65 and method for preparing lipopeptid by using same | 中国科学院沈阳应用生态研究所 | 2024-11-05 | — | — | CN | disclosed |
| US-20240360179-A1 | STAPLED PEPTIDES AND METHODS THEREOF | PARABILIS MEDICINES, INC. | 2024-10-31 | — | — | US | disclosed |
| US-20240352071-A1 | Novel Peptide Compound Or Pharmaceutically Acceptable Salt Thereof | EYEBIO KOREA (KR) | 2024-10-24 | — | — | US | disclosed |
| US-20240299533-A1 | DEOPTIMIZED SARS-COV-2 VARIANTS AND METHODS AND USES THEREOF | CODAGENIX INC. (US) | 2024-09-12 | — | — | US | disclosed |
| WO-2024182375-A1 | COMPOSITIONS COMPRISING NITRIC OXIDE-RELEASING COMPOUNDS FOR TREATING CHOROIDAL VASCULAR DISEASES AND METHODS OF THEIR USE | OPTICGON LLC (US) | 2024-09-06 | — | — | WO | disclosed |
| US-20240285572-A1 | COMPOSITIONS COMPRISING NITRIC OXIDE-RELEASING COMPOUNDS FOR TREATING CHOROIDAL VASCULAR DISEASES AND METHODS OF THEIR USE | OPTICGON LLC | 2024-08-29 | — | — | US | disclosed |
| US-12050228-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2024-07-30 | — | — | US | disclosed |
| US-20240228538-A1 | Novel Peptide Compound Or Pharmaceutically Acceptable Salt Thereof | EYEBIO KOREA (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240228978-A1 | ATTENUATED INFLUENZA VIRUSES AND VACCINES | The Research Foundation for The State of University New york (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240228981-A1 | ATTENUATED VIRUSES USEFUL FOR VACCINES | THE RESEARCH FOUNDATION FOR THE STATE OF UNIV NEW YORK (US) | 2024-07-11 | — | — | US | disclosed |
| CN-118221777-A | Polypeptide for repairing skin wound or mucous membrane injury and application thereof | 四川好医生攀西药业有限责任公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-112041328-B | Dipeptide and pharmaceutical composition containing the same | 志瑞亚新药工业株式会社 | 2024-06-21 | — | — | CN | disclosed |
| US-20240165006-A1 | DERMATOLOGICAL COMPOSTIONS AND USE THEREOF | BONE SCI. BIO LTD. (IL) | 2024-05-23 | — | — | US | disclosed |
| CN-114106100-B | Polypeptide for repairing skin wound or mucous membrane injury and application thereof | 四川好医生攀西药业有限责任公司 | 2024-05-17 | — | — | CN | disclosed |
| CN-117940585-A | Methods for identifying responsiveness to fibroblast growth factor receptor 1 inhibitor therapy | 科隆大学 | 2024-04-26 | — | — | CN | disclosed |
| WO-2024086381-A2 | METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS | ENDEVICA BIO, INC. (US) | 2024-04-25 | — | — | WO | disclosed |
| US-20240116985-A1 | STAPLED PEPTIDES AND METHODS THEREOF | PARABILIS MEDICINES, INC. | 2024-04-11 | — | — | US | disclosed |
| US-20240101982-A1 | PARAOXONASE FUSION POLYPEPTIDES AND RELATED COMPOSITIONS AND METHODS | THERIPION, INC. | 2024-03-28 | — | — | US | disclosed |
| CN-114032271-B | Oyster polypeptide and polypeptide powder with uric acid reducing effect, and preparation method and application thereof | 浙江工业大学 | 2024-03-26 | — | — | CN | disclosed |
| US-20240087866-A1 | ELECTROPHORETIC MASS SPECTROMETRY PROBES AND SYSTEMS AND USES THEREOF | PURDUE RESEARCH FOUNDATION | 2024-03-14 | — | — | US | disclosed |
| EP-4313105-A1 | DERMATOLOGICAL COMPOSITIONS AND USE THEREOF | Bone Sci. Bio Ltd. (IL) | 2024-02-07 | — | — | EP | disclosed |
| CN-117511942-A | Method for specifically knocking down plant circRNA based on CRISPR/RfxCas13d system | 上海交通大学 | 2024-02-06 | — | — | CN | disclosed |
| EP-3431099-B1 | ATTENUATED VIRUSES USEFUL FOR VACCINES | UNIV NEW YORK STATE RES FOUND (US) | 2024-01-03 | — | — | EP | disclosed |
| EP-4294827-A1 | PARAOXONASE FUSION POLYPEPTIDES AND RELATED COMPOSITIONS AND METHODS | Theripion, Inc. (US) | 2023-12-27 | — | — | EP | disclosed |
| US-11854781-B2 | Electrophoretic mass spectrometry probes and systems and uses thereof | PURDUE RESEARCH FOUNDATION (US) | 2023-12-26 | — | — | US | disclosed |
| EP-2139515-B2 | ATTENUATED VIRUSES USEFUL FOR VACCINES | THE RESEARCH FOUNDATION OF THE STATE UNIV OF NEW YORK (US) | 2023-12-20 | — | — | EP | disclosed |
| US-11834481-B1 | Salty taste enhancing peptide derived from dry-cured ham and preparation method thereof | HEFEI UNIVERSITY OF TECHNOLOGY (CN) | 2023-12-05 | — | — | US | disclosed |
| US-11834481-B1 | Salty taste enhancing peptide derived from dry-cured ham and preparation method thereof | HEFEI UNIVERSITY OF TECHNOLOGY (CN) | 2023-12-05 | — | — | US | disclosed |
| CN-117083075-A | Dermatological composition and use thereof | 邦赛生物有限公司 | 2023-11-17 | — | — | CN | disclosed |
| WO-2023218231-A1 | NOVEL ISOLATED PEPTIDES, PROTEIN HYDROLYSATE COMPRISING THE SAID ISOLATED PEPTIDES AND USE THEREOF | BETAGRO PUBLIC COMPANY LIMITED (TH) | 2023-11-16 | — | — | WO | disclosed |
| CN-116987692-A | DNA molecular weight standard substance containing small fragments and production method thereof | 北京元码医学检验实验室有限公司 | 2023-11-03 | — | — | CN | disclosed |
| US-11793870-B2 | Live attenuated strains of foot and mouth disease modified by deoptimization and uses thereof | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2023-10-24 | — | — | US | disclosed |
| CN-113960200-B | Use of metabolic markers for diagnosing ADHD combined tic disorders in children | 首都医科大学附属北京儿童医院 | 2023-06-20 | — | — | CN | disclosed |
| CN-116249708-A | Foot-and-mouth disease live attenuated strain modified through optimization and application thereof | 美国农业部 | 2023-06-09 | — | — | CN | disclosed |
| CN-116199765-A | Method for synthesizing thymus by using modified dipeptide | 江苏诺泰澳赛诺生物制药股份有限公司 | 2023-06-02 | — | — | CN | disclosed |
| US-20230130132-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING AMPHIPHILIC PEPTIDES AND METHODS OF USE THEREOF | BONE SCI. BIO LTD. (IL) | 2023-04-27 | — | — | US | disclosed |
| US-20230117167-A1 | DEOPTIMIZED SARS-CoV-2 AND METHODS AND USES THEREOF | CODAGENIX INC. (US) | 2023-04-20 | — | — | US | disclosed |
| EP-4162030-A1 | LIVE ATTENUATED STRAINS OF FOOT AND MOUTH DISEASE MODIFIED BY DEOPTIMIZATION AND USES THEREOF | The United States of America as represented by the Secretary of Agriculture (US) | 2023-04-12 | — | — | EP | disclosed |
| US-20230066637-A1 | ELECTROPHORETIC MASS SPECTROMETRY PROBES AND SYSTEMS AND USES THEREOF | AMGEN INC. | 2023-03-02 | — | — | US | disclosed |
| US-20230057622-A1 | Recombinant Human Neuregulin Derivatives and Use Thereof | ZENSUN SHANGHAI SCIENCE & TECH CO LTD (CN) | 2023-02-23 | — | — | US | disclosed |
| EP-4125993-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING AMPHIPHILIC PEPTIDES AND METHODS OF USE THEREOF | Bone Sci. Bio Ltd. (IL) | 2023-02-08 | — | — | EP | disclosed |
| US-11566256-B2 | Polynucleotides and polypeptides in plants | MENDEL BIOTECHNOLOGY, INC. (US) | 2023-01-31 | — | — | US | disclosed |
| WO-2023283106-A1 | DEOPTIMIZED SARS-COV-2 VARIANTS AND METHODS AND USES THEREOF | CODAGENIX INC. (US) | 2023-01-12 | — | — | WO | disclosed |
| US-11549101-B2 | Attenuated influenza viruses and vaccines | The Research Foundation for State University of New York (US) | 2023-01-10 | — | — | US | disclosed |
| EP-4096712-A1 | DEOPTIMIZED SARS-COV-2 AND METHODS AND USES THEREOF | Codagenix Inc. (US) | 2022-12-07 | — | — | EP | disclosed |
| CN-115427073-A | Deoptimizing SARS-CoV-2 and its method and use | 科达金尼克斯有限公司 | 2022-12-02 | — | — | CN | disclosed |
| US-20220347285-A1 | ATTENUATED DENGUE VIRUSES | CODAGENIX INC. (US) | 2022-11-03 | — | — | US | disclosed |
| WO-2022201146-A1 | DERMATOLOGICAL COMPOSITIONS AND USE THEREOF | BONE SCI. BIO LTD. (IL) | 2022-09-29 | — | — | WO | disclosed |
| US-20220298492-A1 | ATTENUATED VIRUSES USEFUL FOR VACCINES | THE RESEARCH FOUNDATION FOR THE STATE OF UNIV NEW YORK (US) | 2022-09-22 | — | — | US | disclosed |
| CN-115028682-A | Salt-increasing peptide from dry-cured ham and preparation method thereof | 合肥工业大学 | 2022-09-09 | — | — | CN | disclosed |
| CN-115028682-A | Salt-increasing peptide from dry-cured ham and preparation method thereof | 合肥工业大学 | 2022-09-09 | — | — | CN | disclosed |
| WO-2022178078-A1 | PARAOXONASE FUSION POLYPEPTIDES AND RELATED COMPOSITIONS AND METHODS | THERIPION, INC. (US) | 2022-08-25 | — | — | WO | disclosed |
| EP-4032901-A1 | RECOMBINANT HUMAN NEUREGULIN DERIVATIVES AND USE THEREOF | Zensun (Shanghai) Science & Technology, Co., Ltd. (CN) | 2022-07-27 | — | — | EP | disclosed |
| EP-4004545-A1 | METHODS OF ISOLATING A BIOLOGICAL ENTITY | Cell.copedia GmbH (DE) | 2022-06-01 | — | — | EP | disclosed |
| EP-3991791-A1 | AMINO ACID MIXTURE HAVING CO-AMORPHOUS STRUCTURE | AJINOMOTO CO., INC. (JP) | 2022-05-04 | — | — | EP | disclosed |
| EP-3990014-A1 | ATTENUATED DENGUE VIRUSES | Codagenix Inc. (US) | 2022-05-04 | — | — | EP | disclosed |
| US-20220112237-A1 | AMINO ACID COMPOSITION HAVING CO-AMORPHOUS STRUCTURE | AJINOMOTO CO., INC. (JP) | 2022-04-14 | — | — | US | disclosed |
| EP-3974441-A1 | NOVEL PEPTIDE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | EYEBIO KOREA (KR) | 2022-03-30 | — | — | EP | disclosed |
| CN-113880936-B | Solid-phase synthesis method of abamectin | 浙江湃肽生物有限公司南京分公司 | 2022-03-29 | — | — | CN | disclosed |
| CN-114032271-A | Oyster polypeptide and polypeptide powder with uric acid reducing effect as well as preparation method and application of oyster polypeptide and polypeptide powder | 浙江工业大学 | 2022-02-11 | — | — | CN | disclosed |
| US-20210088539-A1 | AUTOMATED SAMPLE QUALITY ASSESSMENT | METABOLON, INC. | 2021-03-25 | — | — | US | disclosed |
| CN-112236135-A | Dietary products | 癌症研究科技有限公司 | 2021-01-15 | — | — | CN | disclosed |
| US-10890592-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2021-01-12 | — | — | US | disclosed |
| EP-3709991-A1 | DIETARY PRODUCT | Hannon, Greg (GB) | 2020-09-23 | — | — | EP | disclosed |
| CN-110568196-B | Metabolic marker related to low-grade glioma in urine and application thereof | 中国医学科学院基础医学研究所 | 2020-09-18 | — | — | CN | disclosed |
| CN-110568196-B | Metabolic marker related to low-grade glioma in urine and application thereof | 中国医学科学院基础医学研究所 | 2020-09-18 | — | — | CN | disclosed |
| US-20200284805-A1 | BIOMARKERS RELATED TO ORGAN FUNCTION | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2020-09-10 | — | — | US | disclosed |
| US-20200281243-A1 | DIETARY PRODUCT | CANCER RESEARCH TECHNOLOGY LTD (GB) | 2020-09-10 | — | — | US | disclosed |
| US-10634686-B2 | Biomarkers related to organ function | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2020-04-28 | — | — | US | disclosed |
| CN-110568196-A | Metabolic marker related to low-grade glioma in urine and application thereof | 中国医学科学院基础医学研究所 | 2019-12-13 | — | — | CN | disclosed |
| CN-110568196-A | Metabolic marker related to low-grade glioma in urine and application thereof | 中国医学科学院基础医学研究所 | 2019-12-13 | — | — | CN | disclosed |
| US-20180321267-A1 | AUTOMATED SAMPLE QUALITY ASSESSMENT | METABOLON, INC. (US) | 2018-11-08 | — | — | US | disclosed |
| US-20180314790-A1 | System, Method and Apparatus for Determining the Effect of Genetic Variants | METABOLON, INC. | 2018-11-01 | — | — | US | disclosed |
| US-20170370954-A1 | Biomarkers for Fatty Liver Disease and Methods Using the Same | METABOLON, INC. | 2017-12-28 | — | — | US | disclosed |
| US-20170276669-A1 | PRECISE ESTIMATION OF GLOMERULAR FILTRATION RATE FROM MULTIPLE BIOMARKERS | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2017-09-28 | — | — | US | disclosed |
| EP-3221463-A1 | BIOMARKERS FOR FATTY LIVER DISEASE AND METHODS USING THE SAME | Metabolon, Inc. (US) | 2017-09-27 | — | — | EP | disclosed |
| EP-3215633-A1 | SYSTEM, METHOD AND APPARATUS FOR DETERMINING THE EFFECT OF GENETIC VARIANTS | Metabolon, Inc. (US) | 2017-09-13 | — | — | EP | disclosed |
| US-20160231330-A1 | BIOMARKERS RELATED TO ORGAN FUNCTION | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2016-08-11 | — | — | US | disclosed |
| WO-2016081534-A1 | BIOMARKERS FOR FATTY LIVER DISEASE AND METHODS USING THE SAME | METABOLON, INC. (US) | 2016-05-26 | — | — | WO | disclosed |
| WO-2016073547-A1 | SYSTEM, METHOD AND APPARATUS FOR DETERMINING THE EFFECT OF GENETIC VARIANTS | METABOLON, INC. (US) | 2016-05-12 | — | — | WO | disclosed |
| WO-2015042602-A1 | BIOMARKERS RELATED TO ORGAN FUNCTION | UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2015-03-26 | — | — | WO | disclosed |
| US-20150065366-A1 | Biomarkers for Bladder Cancer and Methods Using the Same | METABOLON, INC. | 2015-03-05 | — | — | US | disclosed |
| US-20140343865-A1 | Biomarkers for Kidney Cancer and Methods Using the Same | METABOLON, INC. | 2014-11-20 | — | — | US | disclosed |
| EP-2788763-A2 | BIOMARKERS FOR KIDNEY CANCER AND METHODS USING THE SAME | Metabolon, Inc. (US) | 2014-10-15 | — | — | EP | disclosed |
| US-20140296134-A1 | METHODS AND USES FOR METABOLIC PROFILING FOR CLOSTRIDIUM DIFFICILE INFECTION | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-10-02 | — | — | US | disclosed |
| EP-2776832-A1 | BIOMARKERS FOR BLADDER CANCER AND METHODS USING THE SAME | Metabolon, Inc. (US) | 2014-09-17 | — | — | EP | disclosed |
| EP-2776829-A1 | METHODS AND USES FOR METABOLIC PROFILING FOR CLOSTRIDIUM DIFFICILE INFECTION | The Board of Regents of The University of Texas System (US) | 2014-09-17 | — | — | EP | disclosed |
| US-20140156573-A1 | METHODS FOR GENERATING PREDICTIVE MODELS FOR EPITHELIAL OVARIAN CANCER AND METHODS FOR IDENTIFYING EOC | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2014-06-05 | — | — | US | disclosed |
| WO-2013086365-A2 | BIOMARKERS FOR KIDNEY CANCER AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-06-13 | — | — | WO | disclosed |
| WO-2013070839-A1 | BIOMARKERS FOR BLADDER CANCER AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-05-16 | — | — | WO | disclosed |
| WO-2013070962-A1 | METHODS AND USES FOR METABOLIC PROFILING FOR CLOSTRIDIUM DIFFICILE INFECTION | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-05-16 | — | — | WO | disclosed |
| US-7846902-B2 | Dipeptide-comprising composition for oral administration | KYOWA HAKKO BIO CO., LTD. (JP) | 2010-12-07 | — | — | US | disclosed |
| US-20080305151-A1 | Dipeptide-Comprising Composition for Oral Administration | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2008-12-11 | — | — | US | disclosed |
| EP-1941896-A1 | DIPEPTIDE-CONTAINING COMPOSITION FOR ORAL ADMINISTRATION | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2008-07-09 | — | — | EP | disclosed |
| WO-2007139430-A1 | PEPTIDE SUBSTANCE STIMULATING LIVER TISSUE REGENERATION, PHARMACEUTICAL COMPOSITION ON ITS BASE AND THE METHOD OF ITS APPLICATION | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU 'SIA PEPTIDES' (RU) | 2007-12-06 | — | — | WO | disclosed |
| EP-0612211-B1 | ALTERATION OF RATE AND CHARACTER OF HAIR GROWTH | GILLETTE CO (US) | 2002-06-05 | — | — | EP | disclosed |
| EP-0512435-B1 | Method of crystallizing aspartame | AJINOMOTO KK (JP) | 1997-01-22 | — | — | EP | disclosed |
| US-5444090-A | Applying a synthetase inhibitor | GILLETTE COMPANY, THE, (A DELAWARE CORPORATION) | 1995-08-22 | — | — | US | disclosed |
| EP-0612211-A4 | ALTERATION OF RATE AND CHARACTER OF HAIR GROWTH. | HANDELMAN JOSEPH H (US) | 1994-12-07 | — | — | EP | disclosed |
| EP-0612211-A1 | ALTERATION OF RATE AND CHARACTER OF HAIR GROWTH | HANDELMAN, Joseph H. (US) | 1994-08-31 | — | — | EP | disclosed |
| US-5298648-A | Method of crystallizing aspartame | AJINOMOTO CO., INC. (JP) | 1994-03-29 | — | — | US | disclosed |
| WO-1993008687-A1 | ALTERATION OF RATE AND CHARACTER OF HAIR GROWTH | HANDELMAN JOSEPH H (US) | 1993-05-13 | — | — | WO | disclosed |
| EP-0512435-A1 | Method of crystallizing aspartame | Ajinomoto Co., Inc. (JP) | 1992-11-11 | — | — | EP | disclosed |
| EP-0438873-A1 | Inhibitor of ribonucleotide reductase of herpes viruses | MERCK & CO. INC. (US) | 1991-07-31 | — | — | EP | disclosed |
| JP-H03127737-A | BRANCHED-CHAIN AMINO ACID PREPARATION | OTSUKA PHARMACEUT FACTORY INC | 1991-05-30 | — | — | JP | disclosed |
| JP-S62151156-A | NUTRIENT COMPOSITION | AJINOMOTO CO INC | 1987-07-06 | — | — | JP | disclosed |
| JP-S62151156-A | NUTRIENT COMPOSITION | AJINOMOTO CO INC | 1987-07-06 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12428446-B2 | Peptide compound or pharmaceutically acceptable salt thereof | VIP, FURIN, IAPP | MME 33/4885ALDH1A1 4721/4885MAPT 1317/4885 |
| US-20260098072-A1 | METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS | MC1R, MC4R, MC5R | MME 411/4885ALDH1A1 4441/4885MAPT 1459/4885 |
| US-20240228538-A1 | Novel Peptide Compound Or Pharmaceutically Acceptable Salt Thereof | VIP, NPPA, NGLY1 | MME 37/4885ALDH1A1 4695/4885MAPT 1694/4885 |
| US-20260055137-A1 | NOVEL ISOLATED PEPTIDES, PROTEIN HYDROLYSATE COMPRISING THE SAID ISOLATED PEPTIDES AND USE THEREOF | VIP, ARGLU1, PELP1 | MME 904/4885ALDH1A1 4847/4885MAPT 1585/4885 |
| US-20230117167-A1 | DEOPTIMIZED SARS-CoV-2 AND METHODS AND USES THEREOF | EIF2AK2, ACE2, SARS1 | MME 486/4885ALDH1A1 4757/4885MAPT 3979/4885 |
| US-20240116985-A1 | STAPLED PEPTIDES AND METHODS THEREOF | CTNNB1, APC, CTNNA1 | MME 467/4885ALDH1A1 4142/4885MAPT 2476/4885 |
| US-20240352071-A1 | Novel Peptide Compound Or Pharmaceutically Acceptable Salt Thereof | VIP, NPPA, NGLY1 | MME 37/4885ALDH1A1 4695/4885MAPT 1694/4885 |
| US-20240360179-A1 | STAPLED PEPTIDES AND METHODS THEREOF | CTNNB1, APC, CTNNA1 | MME 479/4885ALDH1A1 4055/4885MAPT 2642/4885 |
| US-20260022384-A1 | ASPARAGINE SYNTHETASE INHIBITORS AND USES THEREOF | ASNS, AARS1, NARS1 | MME 1489/4885ALDH1A1 3160/4885MAPT 2780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.